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Background
Evaluation of myocardial fibrosis has been identified as
an important part of studying remodeling processes and
arrhythmogenesis. While focal fibrosis associated with
tissue necrosis is more likely found in those with prior
cardiovascular disease (CVD), whether diffuse fibrosis
(associated with cellular apoptosis and other pro-fibrotic
processes) is also increased is unknown. We used con-
trast-enhanced CMR to evaluate the association between
CVD in MESA over 10-years with myocardial fibrosis
measured at year-10.
Methods
The MESA study enrolled 6814 participants free of cardio-
vascular disease at baseline (2000-2002). We included
MESA participants who underwent contrast-enhanced
CMR at the MESA follow-up exam at year-10 (N = 1840).
Coronary heart disease (CHD) was defined as myocardial
infarction, resuscitated cardiac arrest, definite angina, or
probable angina (if followed by revascularization) that
occurred between the baseline and 10-year follow-up
exams. We also defined a composite CVD endpoint which
included CHD, congestive heart failure, atrial fibrillation,
stroke and transient ischemic attack. Using CMR, we char-
acterized left ventricular (LV) myocardial fibrosis with -
late-gadolinium enhancement for focal fibrosis (10-12
short-axis and 2 long-axis slices covering the entire LV)
and MOLLI T1 mapping for diffuse interstitial fibrosis
(1 mid-ventricular short-axis slice). Logistic regression
models were used to assess the relationship between the
clinical events and the presence/absence of scar by LGE
and T1 mapping indices (pre-contrast T1, post contrast
T1 at 12 and 25 minutes, and extracellular volume fraction
or ECV) after adjustment for demographics - Model 1:
age, gender and race; and traditional cardiovascular risk
factors - Model 2: Model 1 + blood pressures, hyperten-
sion/lipid medication use, diabetes, HDL and total choles-
terol, body mass index, smoking status, glomerular
filtration rate (post-contrast T1 only). Models with T1
indices were also adjusted for myocardial scar.
Results
Participants were 68 ± 9 years, 52% male, 45% Caucasian,
9% Chinese, 25% African-American, 21% Hispanic, 55%
had hypertension, and 16% diabetes. 146 of 1840 (7.9%)
participants were observed to have myocardial scar by
LGE. The mean values of T1 indices were - precontrast
T1: 977 ± 45 ms; post-contrast T1 at 12’: 456 ± 40 ms;
post-contrast T1 at 25’: 519 ± 41 ms; ECV: 27.1 ± 3.2%.
In logistic regression analysis, the presence of LGE scar
was strongly associated with prior events (see Table 1).
Decreased post-contrast T1 times, indicative of greater
diffuse fibrosis were strongly associated with both end-
points. The association between post-contrast T1 and
CHD (p < 0.05) remained after adjustment for the pre-
sence of myocardial scar by LGE.
Conclusions
Prior CVD events were associated with a greater likeli-
hood of focal LV myocardial fibrosis and a greater
amount of diffuse LV interstitial fibrosis in a free-living
multi-ethnic population.
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Table 1 The coefficients (and associated p-values) from logistic regression models assessing the association between
prior cardiovascular disease and coronary heart disease with myocardial fibrosis indices.
Composite Cardiovascular Disease Coronary Heart Disease
No of events/total
population
Univariate Model 1 Model 2 No of events/total
population
Univariate Model 1 Model 2












Pre-contrast T1 (ms) ×
10^(-3)
108/1344 0.4 (0.87) -0.7(0.77) -1.3
(0.59)






































Model 1: age, gender and race; and traditional cardiovascular risk factors - Model 2: Model 1 + blood pressures, hypertension/lipid medication use, diabetes, HDL
and total cholesterol, body mass index, smoking status, glomerular filtration rate (post-contrast T1 only).
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